Navigation Links
GenoSpace Expands Its Management Team by Appointing Daniel Meyer as Chief Financial Officer
Date:3/28/2013

CAMBRIDGE, Mass., March 28, 2013 /PRNewswire/ -- GenoSpace, LLC, a company that builds information systems capable of storing and integrating genomic information and other health data for clinical care and advanced research, today announced the addition of Daniel Meyer as Chief Financial Officer.

(Logo: http://photos.prnewswire.com/prnh/20130328/NE84802LOGO)

"We have been working with Dan in an advisory relationship since forming the company, and are pleased to be able to bring him on full time," stated John Quackenbush , PhD., CEO of GenoSpace. "The GenoSpace team has produced incredible successes since we launched and we are getting excellent feedback from our customers and users at clinical labs and research institutions. Our ability to build the senior management team reflects the rapidly growing scale of our business and quality of our pipeline."

Mr. Meyer has spent his entire career in life sciences entrepreneurship, venture capital and investment banking. He covered the healthcare portfolios at Arboretum Ventures and Point Judith Capital, where he focused on investments in life science tools, medical devices, healthcare information technology and services. Prior to his work investing in early stage companies, Mr. Meyer was a member of the health care investment banking team at Credit Suisse First Boston. He was also a co-founder and the General Manager of a medical device startup from inception through prototype development. Mr. Meyer holds a B.A. in Mathematics and Economics from Middlebury College and an M.B.A. from the Tuck School of Business at Dartmouth.

About GenoSpace
At GenoSpace, we are Digital Architects of Genomic Medicine™. GenoSpace is a Cambridge, Massachusetts-based company that has developed robust software systems for securely storing vast amounts of genomic and health data, and providing it in formats specific to its diverse user communities. GenoSpace for Clinical Care™ facilitates clinically actionable interpretation and report generation for precision medicine. GenoSpace for Research™ provides dynamic analysis, visualization and collaboration tools. GenoSpace for Patient Communities™ enables patient-centric exploration and advancement of personalized medicine.

GenoSpace has created an information ecosystem for 21st century genomic medicine—one that enables different participants in precision medicine to realize the potential of our ever-expanding knowledge of human disease and its treatment. Please visit www.GenoSpace.com for more information.

Company Contact:
John Quackenbush
Chief Executive Officer
GenoSpace, LLC
info@genospace.com


'/>"/>
SOURCE GenoSpace, LLC
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. GenoSpace Announces the Launch of a Cloud-Based "Information Ecosystem" for Advancing 21st-Century Personalized Medicine
2. GLM Displays Expands Its Line of Formulate Fabric Displays with the Vibe 10ft Display
3. Shire to Acquire SARcode Bioscience, Expands Presence in Ophthalmology
4. Leading Chemical Manufacturer Expands Biobased Offering through Unique Distribution of Proven Green Spill Absorbent
5. Defying Industry Trends, BBK Worldwide Expands Ownership From Within
6. Abacus International Expands Annual Partnership With HealthEconomics.Com
7. Personal Genome Diagnostics Inc. Licenses Genome-Mapping Technology from Johns Hopkins University and Expands Its Cancer Genome Analysis Business
8. Delta Point Strengthens Management and Expands Consultancy Services with Addition of Former AstraZeneca Executive Michael Hickey
9. SAFC Expands Irvine Facility to Add Dry Powder Media Manufacturing Capabilities
10. Genomas Expands Personalized Medicine Business with Clinical Laboratory Licenses in New York, Florida, California
11. XBiotech Expands Portfolio to Include Biosimilars
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... ... June 23, 2016 , ... ... and Mold) microbial test has received AOAC Research Institute approval 061601. , “This ... introduced last year,” stated Bob Salter, Vice President of Regulatory and Industrial Affairs. ...
(Date:6/23/2016)... 23, 2016   EpiBiome , a precision microbiome ... in debt financing from Silicon Valley Bank (SVB). The ... to advance its drug development efforts, as well as ... "SVB has been an incredible strategic partner to ... traditional bank would provide," said Dr. Aeron Tynes ...
(Date:6/23/2016)... ... June 23, 2016 , ... In a new case report published ... how a patient who developed lymphedema after being treated for breast cancer benefitted from ... the paradigm for dealing with this debilitating, frequent side effect of cancer treatment. ...
(Date:6/23/2016)... June 23, 2016 ... 2016;12(1):22-8 http://doi.org/10.17925/OHR.2016.12.01.22 Published recently ... peer-reviewed journal from touchONCOLOGY, Andrew D Zelenetz ... of cancer care is placing an increasing burden ... expensive biologic therapies. With the patents on many ...
Breaking Biology Technology:
(Date:5/16/2016)... YORK , May 16, 2016   EyeLock ... solutions, today announced the opening of an IoT Center ... to strengthen and expand the development of embedded iris ... an unprecedented level of convenience and security with unmatched ... authenticate one,s identity aside from DNA. EyeLock,s platform uses ...
(Date:5/3/2016)... 3, 2016  Neurotechnology, a provider of high-precision ... Automated Biometric Identification System (ABIS) , a complete ... MegaMatcher ABIS can process multiple complex biometric transactions ... of fingerprint, face or iris biometrics. It leverages ... and MegaMatcher Accelerator , which have been ...
(Date:4/26/2016)... and LONDON , ... Finacle, part of EdgeVerve Systems, a product subsidiary ... Onegini today announced a partnership to integrate the ...      (Logo: http://photos.prnewswire.com/prnh/20151104/283829LOGO ) ... provide their customers enhanced security to access and ...
Breaking Biology News(10 mins):